ArticleArchives of microbiology2026
eIF3i inhibits nelson bay orthoreovirus replication via interaction with the σNS protein.
Article in Archives of microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
L929 cells exhibit relatively strong resistance to infection by Nelson Bay orthoreovirus (NBV), primarily due to the unique virus-host interaction that suppresses NBV infection at multiple stages, including viral entry, genome replication, and virion assembly. This study investigates the role of host factor eIF3i in NBV replication. Co-immunoprecipitation and immunofluorescence co-localization assays were performed to verify whether eIF3i interacts with the σNS protein in vitro. The results demonstrated that eIF3i significantly inhibits NBV replication through specific binding to σNS. This finding not only provides mechanistic insights into host protein-mediated regulation of viral replication, but also offers a theoretical basis for developing novel anti-NBV therapeutic strategies.
Indexed as
Identifiers
42862352What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.